Roche completes $1.9B acquisition of oncology EHR vendor Flatiron Health

Roche closed its acquisition of oncology EHR vendor Flatiron Health, the Swiss pharmaceutical and diagnostics company confirmed April 6.

Roche purchased the New York City-based startup for $1.9 billion on a "fully diluted basis, subject to certain adjustments," according to an April 6 statement.

Under the agreement, Flatiron Health will continue its operations as a separate legal entity. Flatiron Health, founded by two former Google employees and backed by Google's parent company Alphabet, analyzes data it collects from its oncology-specific EHR to improve cancer treatments.

Roche announced its intent to acquire Flatiron Health in February. At the time, Roche already had a 12.6 percent stake in the healthcare startup.

The acquisition will advance both companies' focus on data-driven personalized oncology care, according to Roche officials.

More articles on health IT:
English hospital deploys Epic EHR alert to identify sepsis: 3 things to know
Startup Insider: Figure 1 CMO Dr. Joshua Landy talks building 'Instagram for doctors'
Former US Chief Data Scientist DJ Patil: NIH must partner with Google, Amazon, others to drive AI advancements

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months